MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $958 | +43.6% | 145,654 | -95.0% | 0.04% | +33.3% |
| Q1 2023 | $667 | -99.9% | 2,913,091 | 0.0% | 0.03% | -10.8% |
| Q4 2022 | $709,629 | -37.0% | 2,913,091 | 0.0% | 0.04% | -41.3% |
| Q3 2022 | $1,126,000 | -36.1% | 2,913,091 | 0.0% | 0.06% | -43.8% |
| Q2 2022 | $1,762,000 | +0.4% | 2,913,091 | 0.0% | 0.11% | +24.4% |
| Q1 2022 | $1,755,000 | -77.4% | 2,913,091 | 0.0% | 0.09% | -70.2% |
| Q4 2021 | $7,778,000 | -3.3% | 2,913,091 | 0.0% | 0.30% | +7.5% |
| Q3 2021 | $8,040,000 | -3.2% | 2,913,091 | 0.0% | 0.28% | -4.1% |
| Q2 2021 | $8,302,000 | -16.9% | 2,913,091 | 0.0% | 0.29% | -13.6% |
| Q1 2021 | $9,992,000 | +29.9% | 2,913,091 | 0.0% | 0.34% | +37.2% |
| Q4 2020 | $7,691,000 | -15.4% | 2,913,091 | 0.0% | 0.25% | -21.3% |
| Q3 2020 | $9,089,000 | -24.5% | 2,913,091 | 0.0% | 0.31% | -40.6% |
| Q2 2020 | $12,031,000 | +156.5% | 2,913,091 | 0.0% | 0.53% | +65.3% |
| Q1 2020 | $4,690,000 | -35.1% | 2,913,091 | 0.0% | 0.32% | -21.8% |
| Q4 2019 | $7,224,000 | +47.6% | 2,913,091 | 0.0% | 0.41% | +15.2% |
| Q3 2019 | $4,894,000 | -32.8% | 2,913,091 | 0.0% | 0.36% | -43.3% |
| Q2 2019 | $7,283,000 | -18.6% | 2,913,091 | 0.0% | 0.63% | -39.5% |
| Q1 2019 | $8,943,000 | +16.3% | 2,913,091 | 0.0% | 1.03% | +8.8% |
| Q4 2018 | $7,691,000 | -38.7% | 2,913,091 | 0.0% | 0.95% | -31.8% |
| Q3 2018 | $12,555,000 | +9.4% | 2,913,091 | 0.0% | 1.39% | +7.2% |
| Q2 2018 | $11,478,000 | – | 2,913,091 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|